On the origin of labeled RNA in the cytoplasm of mitotic root tip cells of Vicia faba.

N. Das,E. P. Siegel,M. Alfert

DOI: https://doi.org/10.1016/0014-4827(65)90310-1

IF: 4.145

1965-10-01

Experimental Cell Research

Abstract:

What problem does this paper attempt to address?

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

Jianglong Kong,Runxuan Chu,Junjie Wen,Hongrui Yu,Jiawen Liu,Yuting Sun,Meiru Mao,Xiaohan Ge,Zixin Jin,Weimin Huang,Na Hu,Yi Zhang,David Y. Wang,Yi Wang

DOI: https://doi.org/10.1016/j.cej.2024.153023

IF: 15.1

2024-01-01

Chemical Engineering Journal

Abstract:Vascular recanalization intervention is the primary recommended approach for the treatment of ischemic stroke. However, the damage caused by cerebral ischemia-reperfusion (I/R) poses a significant challenge for effective treatment. The aim of this study was to address this challenge by developing multifunctional nanoparticles (NPs). Cu4.6O NP was encapsulated by zein-Se-Se-DHA (Dz), the diselenide bond-conjugated zein and docosahexaenoic acid (DHA), and then coated by platelet membrane (PLTM) to form Cu4.6O@Dz@PLTM (MDzCu) NP. MDzCu with the PLTM coating showed strong targeting ability to the cerebral ischemic lesions in the rat model of cerebral I/R injury. Furthermore, in the reactive oxygen species (ROS)-rich brain microenvironment, both Cu4.6O and DHA are released from MDzCu, exerting ROS scavenging, promoting microglia polarization, and providing neuroprotective effects, ultimately alleviating cerebral I/R injury. This study presents several novel findings, such as the use of Cu0/Cu+ NPs for brain-related diseases, ROS scavenger-assisted DHA therapy for the central nervous system (CNS), and the application of stimuli-responsive NPs with diselenides to treat I/R injuries. This study provides insights into the development of stimuli-responsive nanomedicines with cell membrane coatings for the targeted treatment of brain diseases.
Polydopamine nanoparticles attenuate retina ganglion cell degeneration and restore visual function after optic nerve injury

Xiaotong Lou,Yuanyuan Hu,Hong Zhang,Jia Liu,Yin Zhao

DOI: https://doi.org/10.1186/s12951-021-01199-3

2021-12-20

Abstract:Background: Oxidative stress contributes to retina ganglion cells (RGCs) loss in variety of ocular diseases, including ocular trauma, ocular vein occlusion, and glaucoma. Scavenging the excessed reactive oxygen species (ROS) in retinal neurovascular unit could be beneficial to RGCs survival. In this study, a polydopamine (PDA)-based nanoplatform is developed to protect RGCs. Results: The PDA nanoparticles efficiently eliminate multi-types of ROS, protect endothelia and neuronal cells from oxidative damage, and inhibit microglia activation in retinas. In an optic nerve crush (ONC) model, single intravitreal injection of PDA nanoparticles could significantly attenuate RGCs loss via eliminating ROS in retinas, reducing the inflammatory response and maintaining barrier function of retinal vascular endothelia. Comparative transcriptome analysis of the retina implied that PDA nanoparticles improve RGCs survival probably by altering the expression of genes involved in inflammation and ROS production. Importantly, as a versatile drug carrier, PDA nanoparticles could deliver brimonidine (a neuroprotection drug) to synergistically attenuate RGCs loss and promote axon regeneration, thus restore visual function. Conclusions: The PDA nanoparticle-based therapeutic nanoplatform displayed excellent performance in ROS elimination, providing a promising probability for treating retinal degeneration diseases.
Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation

Olga A. Kost,Olga V. Beznos,Nina G. Davydova,Devika S. Manickam,Irina I. Nikolskaya,Anna E. Guller,Petr V. Binevski,Natalia B. Chesnokova,Anatoly B. Shekhter,Natalia L. Klyachko,Alexander V. Kabanov

DOI: https://doi.org/10.1155/2016/5194239

2016-01-01

Oxidative Medicine and Cellular Longevity

Abstract:Use of antioxidants to mitigate oxidative stress during ocular inflammatory diseases has shown therapeutic potential. This work examines a nanoscale therapeutic modality for the eye on the base of antioxidant enzyme, superoxide dismutase 1 (SOD1), termed “nanozyme.” The nanozyme is produced by electrostatic coupling of the SOD1 with a cationic block copolymer, poly(L-lysine)-poly(ethyleneglycol), followed by covalent cross-linking of the complexes with 3,3′-dithiobis(sulfosuccinimidylpropionate) sodium salt. The ability of SOD1 nanozyme as well as the native SOD1 to reduce inflammatory processes in the eye was examined in vivo in rabbits with immunogenic uveitis. Results suggested that topical instillations of both enzyme forms demonstrated anti-inflammatory activity; however, the nanozyme was much more effective compared to the free enzyme in decreasing uveitis manifestations. In particular, we noted statistically significant differences in such inflammatory signs in the eye as the intensities of corneal and iris edema, hyperemia of conjunctiva, lens opacity, fibrin clots, and the protein content in aqueous humor. Clinical findings were confirmed by histological data. Thus, SOD1-containing nanozyme is potentially useful therapeutic agent for the treatment of ocular inflammatory disorders.

cell biology
Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases

Alexander N. Vaneev,Olga A. Kost,Nikolay L. Eremeev,Olga V. Beznos,Anna V. Alova,Peter V. Gorelkin,Alexander S. Erofeev,Natalia B. Chesnokova,Alexander V. Kabanov,Natalia L. Klyachko

DOI: https://doi.org/10.3390/biomedicines9040396

IF: 4.757

2021-04-07

Biomedicines

Abstract:Inflammatory eye diseases remain the most common clinical problem in ophthalmology. The secondary processes associated with inflammation, such as overproduction of reactive oxygen species (ROS) and exhaustion of the endogenous antioxidant system, frequently lead to tissue degeneration, vision blurring, and even blindness. Antioxidant enzymes, such as copper–zinc superoxide dismutase (SOD1), could serve as potent scavengers of ROS. However, their delivery into the eye compartments represents a major challenge due to the limited ocular penetration. This work presents a new therapeutic modality specifically formulated for the eye on the basis of multilayer polyion complex nanoparticles of SOD1 (Nano-SOD1), which is characterized by appropriate storage stability and pronounced therapeutic effect without side reactions such as eye irritation; acute, chronic, and reproductive toxicity; allergenicity; immunogenicity; mutagenicity even at high doses. The ability of Nano-SOD1 to reduce inflammatory processes in the eye was examined in vivo in rabbits with a model immunogenic uveitis—the inflammation of the inner vascular tract of the eye. It was shown during preclinical studies that topical instillations of Nano-SOD1 were much more effective compared to the free enzyme in decreasing uveitis manifestations. In particular, we noted statistically significant differences in such inflammatory signs in the eye as corneal and conjunctival edema, iris hyperemia, and fibrin clots. Moreover, Nano-SOD1 penetrates into interior eye structures more effectively than SOD itself and retains enzyme activity in the eye for a much longer period of time, decreasing inflammation and restoring antioxidant activity in the eye. Thus, the presented Nano-SOD1 can be considered as a potentially useful therapeutic agent for the treatment of ocular inflammatory disorders.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Superoxide Dismutase‐Loaded Nanoparticles Attenuate Myocardial Ischemia‐Reperfusion Injury and Protect against Chronic Adverse Ventricular Remodeling

Peter J. Altshuler,Alexis R. Schiazza,Lijun Luo,Mark R. Helmers,Bonirath Chhay,Jason J. Han,Robin Hu,David Alan Herbst,Andrew Tsourkas,Zhiliang Cheng,Pavan Atluri

DOI: https://doi.org/10.1002/adtp.202100036

IF: 5.003

2021-04-23

Advanced Therapeutics

Abstract:Early revascularization is critical to reduce morbidity after myocardial infarction, although reperfusion incites additional oxidative injury. Superoxide dismutase (SOD) is an antioxidant that scavenges reactive oxygen species (ROS) but has low endogenous expression and rapid myocardial washout when administered exogenously. This study utilizes a novel nanoparticle carrier to improve exogeneous SOD retention while preserving enzyme function. Its role is assessed in preserving cardiac function after myocardial ischemia-reperfusion (I/R) injury. Here, nanoparticle-encapsulated SOD (NP-SOD) exhibits similar enzyme activity as free SOD, measured by ferricytochrome-c assay. In an in vitro I/R model, free and NP-SOD reduce active ROS, preserve mitochondrial integrity and improve cell viability compared to controls. In a rat in vivo I/R injury model, NP-encapsulation of fluorescent-tagged SOD improves intramyocardial retention after direct injection. Intramyocardial NP-SOD administration in vivo improves left ventricular contractility at 3-hours post-reperfusion by echocardiography and 4-weeks by echocardiography and invasive pressure-volume catheter analysis. These findings suggest that NP-SOD mitigates ROS damage in cardiac I/R injury in vitro and maximizes retention in vivo. NP-SOD further attenuates acute injury and protects against myocyte loss and chronic adverse ventricular remodeling, demonstrating potential for translating NP-SOD as a therapy to mitigate myocardial I/R injury.
Cu-Doping Layered Double Hydroxides Nanozyme Integrated with Nitric Oxide Donor for Enhanced Antioxidant Therapy in Retinopathy

Bai Xue,Yu Lu,Shuyu Wang,Tingting Wu,Lulu Wang,Qing Xiao,Wei Jiang,Xiyun Yan,Bing Jiang

DOI: https://doi.org/10.1002/adhm.202401600

2024-07-16

Abstract:The prevalence of retinal neovascular diseases necessitates novel treatments beyond current therapies like laser surgery or anti-VEGF treatments, which often carry significant side effects. A novel therapeutic approach is introduced using copper-containing layered double hydroxides (Cu-LDH) nanozymes integrated with nitric oxide-releasing molecules (GSHNO), forming Cu-LDH@GSHNO aimed at combating oxidative stress within the retinal vascular system. Combination of synthetic chemistry and biological testing, Cu-LDH@GSHNO are synthesized, characterized, and assessed for curative effect in HUVECs and an oxygen-induced retinopathy (OIR) mouse model. The results indicate that Cu-LDH@GSHNO demonstrates SOD-CAT cascade catalytic ability, accompanied with GSH and nitric oxide-releasing capabilities, which significantly reduces oxidative cell damage and restores vascular function, presenting a dual-function strategy that enhances treatment efficacy and safety for retinal vascular diseases. The findings encourage further development and clinical exploration of nanozyme-based therapies, promising a new horizon in therapeutic approaches for managing retinal diseases driven by oxidative stress.
Injectable, antioxidative, and loaded with exosomes/Liproxstatin-1 hydrogel as a potential treatment for retinal ischemia–reperfusion by inhibiting ferroptosis and apoptosis

Mengling You,Rong Rong,Zhuotao Liang,Sijian Xie,Xiaoya Ma,Xiaobo Xia

DOI: https://doi.org/10.1016/j.cej.2024.154509

IF: 15.1

2024-08-11

Chemical Engineering Journal

Abstract:Retinal ischemia–reperfusion is a major cause of vision loss in a variety of ocular diseases, including glaucoma, age-related macular degeneration, diabetic retinopathy, and central retinal artery occlusion. Previous studies have reported the protective effects of injectable hydrogels in optic nerve injury, but reports of multifunctional hydrogels loaded with drugs and bioactive substances that synergistically promote neuroprotection are rare. Here, we designed an injectable, drug-loaded, and reactive oxygen species responsive multifunctional hydrogel. Upon intravitreal injection into a retinal ischemia–reperfusion injury model in mice, the hydrogel released exosomes and liproxstatin-1 over an extended period exceeding a month, leading to a significant recovery of visual function and reduction of retinal ganglion cell loss. The effect was superior to that of the common drug and exosome combination. The results of this study suggest that this multifunctional hydrogel is expected to advance retinal tissue engineering and provide an innovative strategy for acute neuroprotection in retinal ischemia–reperfusion injury.

engineering, chemical, environmental
Neuroprotective and Anti-Inflammatory Activities of Hybrid Small-Molecule SA-10 in Ischemia/Reperfusion-Induced Retinal Neuronal Injury Models

Charles E. Amankwa,Lorea Gamboa Acha,Adnan Dibas,Sai H. Chavala,Steven Roth,Biji Mathew,Suchismita Acharya

DOI: https://doi.org/10.3390/cells13050396

IF: 6

2024-02-25

Cells

Abstract:Embolism, hyperglycemia, high intraocular pressure-induced increased reactive oxygen species (ROS) production, and microglial activation result in endothelial/retinal ganglion cell death. Here, we conducted in vitro and in vivo ischemia/reperfusion (I/R) efficacy studies of a hybrid antioxidant–nitric oxide donor small molecule, SA-10, to assess its therapeutic potential for ocular stroke. Methods: To induce I/R injury and inflammation, we subjected R28 and primary microglial cells to oxygen glucose deprivation (OGD) for 6 h in vitro or treated these cells with a cocktail of TNF-α, IL-1β and IFN-γ for 1 h, followed by the addition of SA-10 (10 μM). Inhibition of microglial activation, ROS scavenging, cytoprotective and anti-inflammatory activities were measured. In vivo I/R-injured mouse retinas were treated with either PBS or SA-10 (2%) intravitreally, and pattern electroretinogram (ERG), spectral-domain optical coherence tomography, flash ERG and retinal immunocytochemistry were performed. Results: SA-10 significantly inhibited microglial activation and inflammation in vitro. Compared to the control, the compound SA-10 significantly attenuated cell death in both microglia (43% vs. 13%) and R28 cells (52% vs. 17%), decreased ROS (38% vs. 68%) production in retinal microglia cells, preserved neural retinal function and increased SOD1 in mouse eyes. Conclusion: SA-10 is protective to retinal neurons by decreasing oxidative stress and inflammatory cytokines.

cell biology
Polymer-Based Nanoparticles with Probucol and Lithocholic Acid: A Novel Therapeutic Approach for Oxidative Stress-Induced Retinopathies

Susbin Raj Wagle,Bozica Kovacevic,Corina Mihaela Ionescu,Thomas Foster,Patrick Lim,Alicia Brunet,Samuel McLenachan,Livia Carvalho,Momir Mikov,Armin Mooranian,Hani Al-Salami

DOI: https://doi.org/10.1021/acs.molpharmaceut.4c00269

2024-07-01

Abstract:Oxidative stress is pivotal in retinal disease progression, causing dysfunction in various retinal components. An effective antioxidant, such as probucol (PB), is vital to counteract oxidative stress and emerges as a potential candidate for treating retinal degeneration. However, the challenges associated with delivering lipophilic drugs such as PB to the posterior segment of the eye, specifically targeting photoreceptor cells, necessitate innovative solutions. This study uses formulation-based spray dry encapsulation technology to develop polymer-based PB-lithocholic acid (LCA) nanoparticles and assesses their efficacy in the 661W photoreceptor-like cell line. Incorporating LCA enhances nanoparticles' biological efficacy without compromising PB stability. In vitro studies demonstrate that PB-LCA nanoparticles prevent reactive oxygen species (ROS)-induced oxidative stress by improving cellular viability through the nuclear erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway. These findings propose PB-LCA nanoparticles as a promising therapeutic strategy for oxidative stress-induced retinopathies.
Impact Of Deposition Parameters On The Characterizations Of Highly Orientated Aluminum Nitride For Film Bulk Acoustic Resonator Device

N. Jiang,Rajnish Sharma,H. Feng,Zhe Wang,Xiaowei Wang

DOI: https://doi.org/10.1142/S1465876303001721

2003-09-01

International Journal of Computational Engineering Science

Abstract:AlN thin films were grown on Si(100) and Al/Si(100) substrates by pulsed dc sputtering system using 99.999% purity aluminum as target, and Ar+N2 gas mixture as precursor. The impact of deposition parameters on material properties has been investigated has been investigated. A good correlation between film crytallinity and dc power, as well as gas pressure, was addressed by x-ray diffraction, and verified by scanning electron microscope (SEM). It is found that highly c-axis oriented h-AlN can be obtained at low gas pressure and low deposition rate. For AlN on Al/Si(100) substrate, micro-crack was observed, which was assigned to the large thermal stress between AlN film and Al layer. Crack-free surface has been achieved by reducing the deposition temperature. The deposition mechanism of AlN deposition is discussed.
Mitochondria-targeted nanozymes eliminate oxidative damage in retinal neovascularization disease

Bai Xue,Mengyue Ge,Kelong Fan,Xinglu Huang,Xiyun Yan,Wei Jiang,Bing Jiang,Zhenglin Yang

DOI: https://doi.org/10.1016/j.jconrel.2022.08.026

Abstract:Retinal neovascularization is typically accompanied by hypoxia-induced oxidative injury in the vascular system. This study developed an ultrasmall (6-8 nm) platinum (Pt) nanozyme loaded mitochondria-targeted liposome (Pt@MitoLipo) to alleviate hypoxia and eliminate excess reactive oxygen species (ROS) for effective retinal neovascularization disease therapy. Pt nanozymes possess superoxide dismutase (SOD) and catalase (CAT) cascade enzyme-like activities, which convert cytotoxic O2•- and H2O2 into nontoxic H2O and O2. Triphenylphosphonium (TPP)-conjugated liposomes were coated on the surface of Pt nanozymes to increase their biocompatibility and help them penetrate the cell membrane, escape from the lysosomal barrier, and target mitochondria, thus achieving precise scavenging of mitochondrial O2•- and relief from hypoxia. Using an oxygen-induced retinopathy (OIR) mouse model, we demonstrated that Pt@MitoLipo nanozymes significantly suppressed hypoxia-induced abnormal neovascularization and facilitated avascular normalization of the retina in vivo without any noticeable toxicity. This study provides a promising way to break through cellular barriers and target scavenging mitochondrial O2•- and illustrates the potential of ROS-scavenging and hypoxia relief in retinal neovascularization disease therapy.
Effect of phenobarbital administration on the subcellular distribution of 125-I-thyroxine in rat liver: mportance of microsomal binding.

H. L. Schwartz,G. Bernstein,J. Oppenheimer

DOI: https://doi.org/10.1210/ENDO-84-2-270

IF: 5.051

1969-02-01

Endocrinology

Abstract:The subcellular distribution of 125I-thyroxine was determined in homogenates of livers from control and phenobarbital-stimulated rats 35 min following intravenous injection of tracer. Differential centrifugation in 0.25M sucrose indicated that 54% of radioactivity is associated with the microsomal fraction in control animals after appropriate corrections were made for thyroxine bound to trapped plasma proteins. In phenobarbital-treated animals the percentage radioactivity in the microsomal fraction rose to 65 (p>.001). Similar distributions were observed when 131I-T4 was added directly to the homogenate prior to fractionation. Thyroxine associated with tissue fractions could be extracted quantitatively with serum and acid butanol. These findings indicate that the partition of thyroxine among subcellular fractions under in vitro conditions is determined by equilibria among surface binding sites. If the same distribution equilibria characterize the in vivo state, 90% of the increase in liver/plasma concentr...
Zwitterionic Poly(Lysine Methacrylate) Brush As an Effective Carrier for Drug Delivery

Dingcheng Zhu,Jianbin Tang,Youqing Shen

DOI: https://doi.org/10.1016/j.jconrel.2015.05.042

IF: 11.467

2015-01-01

Journal of Controlled Release

Abstract:Copper/zinc superoxide dismutase (CuZnSOD; SOD1) is widely considered as a potential therapeutic candidate for pathologies involving oxidative stress, but its application has been greatly hindered by delivery issues. In our previous study, nanoformulated SOD1 (cl-nanozyme) was shown to decrease infarct volume and improve sensorimotor functions after a single intravenous (IV) injection in a rat middle cerebral artery occlusion (MCAO) model of ischemia/reperfusion (I/R) injury (stroke). However, it remained unclear how cl-nanozyme was able to deliver SOD1 to the brain and exert therapeutic efficacy. The present study aims to answer this question by exploring micro-distribution pattern of cl-nanozyme in the rat brain after stroke. Immunohistochemistry studies demonstrated cl-nanozyme co-localization with fibrin along damaged arteries and capillaries in the ischemic hemisphere. We further found that cl-nanozyme can be cross-linked into thrombi formed after I/R injury in the brain, and this effect is independent of animal species (rat/mouse) used for modeling I/R injury. This work is also the first report reinforcing therapeutic potential of cl-nanozyme in a well-characterized mouse MCAO model of I/R injury.
pH-Responsive polymer boosts cytosolic siRNA release for retinal neovascularization therapy

Shuai Guo,Chunhui Li,Changrong Wang,Xiaowen Cao,Xinyue Liu,Xing-Jie Liang,Yuanyu Huang,Yuhua Weng

DOI: https://doi.org/10.1016/j.apsb.2023.09.001

Abstract:Small interfering RNA (siRNA) has a promising future in the treatment of ocular diseases due to its high efficiency, specificity, and low toxicity in inhibiting the expression of target genes and proteins. However, due to the unique anatomical structure of the eye and various barriers, delivering nucleic acids to the retina remains a significant challenge. In this study, we rationally design PACD, an A-B-C type non-viral vector copolymer composed of a hydrophilic PEG block (A), a siRNA binding block (B) and a pH-responsive block (C). PACDs can self-assemble into nanosized polymeric micelles that compact siRNAs into polyplexes through simple mixing. By evaluating its pH-responsive activity, gene silencing efficiency in retinal cells, intraocular distribution, and anti-angiogenesis therapy in a mouse model of hypoxia-induced angiogenesis, we demonstrate the efficiency and safety of PACD in delivering siRNA in the retina. We are surprised to discover that, the PACD/siRNA polyplexes exhibit remarkable intracellular endosomal escape efficiency, excellent gene silencing, and inhibit retinal angiogenesis. Our study provides design guidance for developing efficient nonviral ocular nucleic acid delivery systems.
Alleviation of ischemia–reperfusion induced renal injury by chemically modified SOD2 mRNA delivered via lipid nanoparticles

Yutong Hou,Sihao Lin,Jia Xia,Yu Zhang,Yanan Yin,Masha Huang,Yingjie Xu,Wen Yang,Yingjian Zhu

DOI: https://doi.org/10.1016/j.omtn.2023.102067

IF: 10.183

2023-10-28

Molecular Therapy — Nucleic Acids

Abstract:Ischemia–reperfusion injury (IRI) is a major cause of acute kidney injury, which is a serious clinical condition with no effective pharmacological treatment. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) significantly alleviate kidney IRI; however, the underlying mechanisms and key molecules conferring renoprotection remain elusive. In this study, we characterized the protein composition of MSC-EVs using a proteomics approach and found that mitochondrial protein superoxide dismutase 2 (SOD2) was enriched in MSC-EVs. Using lipid nanoparticles (LNP), we successfully delivered chemically modified SOD2 mRNA into kidney cells and mice with kidney IRI. We demonstrated that SOD2 mRNA-LNP treatment decreased cellular reactive oxygen species (ROS) in cultured cells and ameliorated renal damage in IRI mice, as indicated by reduced levels of serum creatinine and restored tissue integrity compared to the control mRNA-LNP-injected group. Thus, the modulation of mitochondrial ROS levels through SOD2 upregulation by SOD2 mRNA-LNP delivery could be a novel therapeutic method for ischemia–reperfusion-induced acute kidney injury.

medicine, research & experimental
Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke

Yi Li,Jun Liao,Liyan Xiong,Zhicheng Xiao,Fei Ye,Yun Wang,Ting Chen,Linzhang Huang,Min Chen,Zhe-Sheng Chen,Tingfang Wang,Chuan Zhang,Ying Lu

DOI: https://doi.org/10.1016/j.jconrel.2024.02.039

IF: 11.467

2024-03-18

Journal of Controlled Release

Abstract:Ischemia-reperfusion injury is caused by excessive production of reactive oxygen species (ROS) and inflammation accompanied by ischemic injury symptoms and blood–brain barrier (BBB) dysfunction. This causes neuronal damage, for which no effective treatments or drugs exist. Herein, we provided a stepwise targeted drug delivery strategy and successfully prepared multifunctional ORD@SHp@ANG nanoparticles (NPs) that consist of a stroke homing peptide (DSPE-PEG 2000 -SHp), BBB-targeting peptide (DSPE-PEG 2000 -ANG), and ROS-responsive Danshensu (salvianic acid A) chain self-assembly. ORD@SHp@ANG NPs effectively crossed the BBB by ANG peptide and selectively targeted the ischemic brain sites using stroke-homing peptide. The results showed that ORD@SHp@ANG NPs can effective at scavenging ROS, and protect SH-SY5Y cells from oxidative damage in vitro. Furthermore, ORD@SHp@ANG NPs showed excellent biocompatibility. These NPs recognized brain endothelial cells and crossed the BBB, regulated the transformation of microglia into the anti-inflammatory phenotype, and inhibited the production of inflammatory factors in a rat ischemia-reperfusion model, thereby reducing cerebral infarction, neuronal apoptosis and preserving BBB integrity. Sequencing revealed that ORD@SHp@ANG NPs promote cell proliferation, activate immune responses, suppress inflammatory responses, and ameliorate ischemic stroke. In conclusion, this study reports a simple and promising drug delivery strategy for managing ischemic stroke.

pharmacology & pharmacy,chemistry, multidisciplinary
Total structure of the highly modified peptide antibiotic components of thiopeptin.

O. Hensens,G. Albers-Schönberg

DOI: https://doi.org/10.7164/ANTIBIOTICS.36.814

1983-07-01

Abstract:On the basis of 1H and 13C NMR evidence, the structures of two series of the highly modified sulfur-containing peptide antibiotic thiopeptin were elucidated.
Preserving Retinal Structure and Function with the Novel Nitroxide Antioxidant, DCTEIO

Cassie L Rayner,Steven E Bottle,Alexander P Martyn,Nigel L Barnett

DOI: https://doi.org/10.1007/s11064-023-03978-w

Abstract:Oxidative stress is a major contributor to progressive neurodegenerative disease and may be a key target for the development of novel preventative and therapeutic strategies. Nitroxides have been successfully utilised to study changes in redox status (biological probes) and modulate radical-induced oxidative stress. This study investigates the efficacy of DCTEIO (5,6-dicarboxy-1,1,3,3-tetraethyllisoindolin-2-yloxyl), a stable, kinetically-persistent, nitroxide-based antioxidant, as a retinal neuroprotectant. The preservation of retinal function following an acute ischaemic/reperfusion (I/R) insult in the presence of DCTEIO was quantified by electroretinography (ERG). Inflammatory responses in retinal glia were analysed by GFAP and IBA-1 immunohistochemistry, and retinal integrity assessed by histology. A nitroxide probe combined with flow cytometry provided a rapid technique to assess oxidative stress and the mitigation offered by antioxidant compounds in cultured 661W photoreceptor cells. DCTEIO protected the retina from I/R-induced damage, maintaining retinal function. Histological analysis showed preservation of retinal integrity with reduced disruption and disorganisation of the inner and outer nuclear layers. I/R injury upregulated GFAP expression, indicative of retinal stress, which was significantly blunted by DCTEIO. The number of 'activated' microglia, particularly in the outer retina, in response to cellular stress was also significantly reduced by DCTEIO, potentially suggesting reduced inflammasome activation and cell death. DCTEIO mitigated oxidative stress in 661W retinal cell cultures, in a dose-dependent fashion. Together these findings demonstrate the potential of DCTEIO as a neuroprotective therapeutic for degenerative diseases of the CNS that involve an ROS-mediated component, including those of the retina e.g. age-related macular degeneration and glaucoma.
The Adaptationist-Byproduct Debate on the Evolution of Religion: Five Misunderstandings of the Adaptationist Program

R. Sosis

DOI: https://doi.org/10.1163/156770909X12518536414411

Abstract:The primary debate among scholars who study the evolution of religion concerns whether religion is an adaptation or a byproduct. The dominant position in the field is that religious beliefs and behaviors are byproducts of cognitive processes and behaviors that evolved for other purposes. A smaller group of scholars maintain that religion is an adaptation for extending human cooperation and coordination. Here I survey five critiques of the adapationist position and offer responses to these critiques. Much of the debate can be resolved by clearly defining important but ambiguous terms in the debate, such as religion, adaptation, adaptive, and trait, as well as clarifying several misunderstandings of evolutionary processes. I argue that adaptationist analyses must focus on the functional effects of the religious system, the coalescence of independent parts that constitute the fabric of religion.
Pachymic Acid Alleviates Oxidative Damage of Retinal Cells Induced by Sodium Iodate or Hydrogen Peroxide by Activating the Nrf2/HO-1 Signaling Pathway

Chengyao Qin,Xi Chen,Tianming Hu,Wenxiu Sun,Zehao Liu,Min Li,Yan Shao,Wei Wei

DOI: https://doi.org/10.1177/1934578x241228146

IF: 1.496

2024-01-01

Natural Product Communications

Abstract:Background: Pachymic acid (PA), extracted from the traditional Chinese medicinal herb Poria cocos ( P cocos) is reported to protect organs such as the liver and lungs from damage. This study investigated the effect of PA on oxidative stress in the retina in vivo and in vitro. Methods: In vitro, retinal pigment epithelial (RPE) cells were treated with hydrogen peroxide to establish a cell model of oxidative damage. The viability of ARPE-19 cells was measured using an MTT kit. Apoptosis of the cells was detected using flow cytometry, and the expression of Caspase-3, Bax, and Bcl-2 was determined. The oxidative stress level was evaluated by observing the production of superoxide dismutase, catalase, and GSH-Px using ELISA in mice serum. The retinal oxidative damage model was induced by intravenous injection of sodium iodate (SI) into the tail vein of mice. OCT, HE, and TUNEL staining monitored the structure and the apoptosis of the mouse retina. The regulatory oxidative factors nuclear transcription factor E2-related factor 2 (Nrf2) and HO-1 were determined using fluorescence staining. Results: H 2 O 2 decreased the viability of RPE cells, which was recovered after PA administration and was shown to reduce the cell apoptosis rate, the expression of Bax, caspase-3, and the production of ROS. In vivo, the thinning of the retina and the apoptosis rate in the retinal tissue of mice caused by the administration of SI were reversed by treatment with PA. Furthermore, PA administration caused the translocation of Nrf2 and increased the expression of HO-1, and the application of these inhibitors inhibited this effect. Conclusion: PA protects RPE cells from oxidative stress and apoptosis by activating the Nrf2/HO-1 pathway, and it prevents retinal damage by halting the progression of retinal thinning in a mouse model of retinal oxidative damage.

chemistry, medicinal,food science & technology

On the origin of labeled RNA in the cytoplasm of mitotic root tip cells of Vicia faba.

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

Polydopamine nanoparticles attenuate retina ganglion cell degeneration and restore visual function after optic nerve injury

Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation

Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases

Superoxide Dismutase‐Loaded Nanoparticles Attenuate Myocardial Ischemia‐Reperfusion Injury and Protect against Chronic Adverse Ventricular Remodeling

Cu-Doping Layered Double Hydroxides Nanozyme Integrated with Nitric Oxide Donor for Enhanced Antioxidant Therapy in Retinopathy

Injectable, antioxidative, and loaded with exosomes/Liproxstatin-1 hydrogel as a potential treatment for retinal ischemia–reperfusion by inhibiting ferroptosis and apoptosis

Neuroprotective and Anti-Inflammatory Activities of Hybrid Small-Molecule SA-10 in Ischemia/Reperfusion-Induced Retinal Neuronal Injury Models

Polymer-Based Nanoparticles with Probucol and Lithocholic Acid: A Novel Therapeutic Approach for Oxidative Stress-Induced Retinopathies

Impact Of Deposition Parameters On The Characterizations Of Highly Orientated Aluminum Nitride For Film Bulk Acoustic Resonator Device

Mitochondria-targeted nanozymes eliminate oxidative damage in retinal neovascularization disease

Effect of phenobarbital administration on the subcellular distribution of 125-I-thyroxine in rat liver: mportance of microsomal binding.

Zwitterionic Poly(Lysine Methacrylate) Brush As an Effective Carrier for Drug Delivery

pH-Responsive polymer boosts cytosolic siRNA release for retinal neovascularization therapy

Alleviation of ischemia–reperfusion induced renal injury by chemically modified SOD2 mRNA delivered via lipid nanoparticles

Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke

Total structure of the highly modified peptide antibiotic components of thiopeptin.

Preserving Retinal Structure and Function with the Novel Nitroxide Antioxidant, DCTEIO

The Adaptationist-Byproduct Debate on the Evolution of Religion: Five Misunderstandings of the Adaptationist Program

Pachymic Acid Alleviates Oxidative Damage of Retinal Cells Induced by Sodium Iodate or Hydrogen Peroxide by Activating the Nrf2/HO-1 Signaling Pathway